Table 1.
Strategy | IR+ improved follow-up | Primary test | Confirmation test after positive primary test |
Current | No | Pap test/3 years | Pap test or HPV |
Pap/Pap | Yes | Pap test/3 years | Pap test |
Pap/p16Ki67 | Yes | Pap test/3 years | p16/Ki67 |
HPV/Pap-5y* | Yes | HPV/5 years | Pap test |
HPV/Pap-3y* | Yes | HPV/3 years | Pap test |
HPV/Pap-10y* | Yes | HPV/10 years | Pap test |
HPV/p16Ki67-5y* | Yes | HPV/5 years | p16/Ki67 |
HPV/p16Ki67-10y* | Yes | HPV/10 years | p16/Ki67 |
p16Ki67/p16Ki67 | Yes | HPV/3 years | p16/Ki67 |
*Women aged 25–35 are not eligible for HPV screening and receive a Pap test every 3 years instead. Women who tested HPV+/confirmation− go through double testing (HPV+Pap) the following year.
HPV, human papillomavirus; IndScr, individual screening; IR, invitation+recall for woman who did not participate in IndScr in the last 3 years (non-participant); OS, organised screening; Pap, Papanicolaou.